Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 8/20 | 0.74 |
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | HPGD | P15428 | 3/20 | 0.74 |
| ▸ | ACHE | P22303 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.48 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | FASN | P49327 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655640 | 1.00 | CYP3A4 (0.74) | CYP3A4MEN1KMT2AHPGDACHE | |
| SCHEMBL2380154 | 0.88 | CYP3A4 (0.61) | CYP3A4MEN1KMT2AHPGDACHE | |
| 2,4,6-Trihydroxyacetophenone SCHEMBL105416 | 0.85 | CYP3A4 (1.00) | CYP3A4MEN1KMT2AHPGDACHE | |
| SCHEMBL7766611 | 0.84 | CYP3A4 (0.72) | CYP3A4MEN1KMT2AHPGDACHE | |
| 2,4,6-Trihydroxyacetophenone SCHEMBL564755 | 0.83 | CYP3A4 (0.95) | CYP3A4MEN1KMT2AHPGDACHE | |
| 2,4,6-Trihydroxyacetophenone SCHEMBL1421619 | 0.83 | CYP3A4 (0.95) | CYP3A4MEN1KMT2AHPGDACHE | |
| SCHEMBL2648126 | 0.82 | CYP3A4 (0.54) | CYP3A4MEN1KMT2AHPGDACHE | |
| Orsellinic Acid SCHEMBL522294 | 0.82 | CYP3A4 (1.00) | CYP3A4MEN1KMT2AHPGDACHE | |
| SCHEMBL30597490 | 0.82 | CYP3A4 (0.54) | CYP3A4MEN1KMT2AHPGDACHE | |
| SCHEMBL31738485 | 0.80 | CYP3A4 (0.67) | CYP3A4MEN1KMT2AHPGDACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188266-A1 | MODIFIED PHENOLIC RESINS FOR MAKING COMPOSITE PRODUCTS | Bakelite UK Holding Ltd. (GB) | 2025-06-12 | — | — | US | disclosed |
| US-12303970-B2 | Foundry mix including resorcinol | Novis Works, LLC (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4490213-A1 | MODIFIED PHENOLIC RESINS FOR MAKING COMPOSITE PRODUCTS | Bakelite UK Holding Ltd. (GB) | 2025-01-15 | — | — | EP | disclosed |
| US-20240174563-A1 | FIRE- RESISTANT OVERLAYS, FIRE-RESISTANT PANELS, AND PROCESSES FOR MAKING AND USING SAME | GP BUILDING PRODUCTS SERVICES LLC | 2024-05-30 | — | — | US | disclosed |
| US-20230321717-A1 | FOUNDRY MIX INCLUDING RESORCINOL | Novis Works, LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-11780112-B2 | Binders containing an aldehyde-based resin and an isocyanate-based resin and methods for making composite lignocellulose products therefrom | BAKELITE CHEMICALS LLC | 2023-10-10 | — | — | US | disclosed |
| WO-2023170208-A1 | MODIFIED PHENOLIC RESINS FOR MAKING COMPOSITE PRODUCTS | Bakelite UK Holding Ltd. (GB) | 2023-09-14 | — | — | WO | disclosed |
| EP-4225712-A1 | FIRE- RESISTANT OVERLAYS, FIRE-RESISTANT PANELS, AND PROCESSES FOR MAKING AND USING SAME | GP Building Products Services LLC (US) | 2023-08-16 | — | — | EP | disclosed |
| US-11712735-B2 | Foundry mix including resorcinol | Novis Works, LLC (US) | 2023-08-01 | — | — | US | disclosed |
| US-11542370-B2 | Aromatic alcohol-lignin-aldehyde resins and processes for making and using same | Bakelite UK Holding Ltd. | 2023-01-03 | — | — | US | disclosed |
| US-7316877-B2 | Bisazo-based charge transport materials having 4-oxo-2,5-cyclohexadiene-1-ylidenyl groups | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-08 | — | — | US | disclosed |
| WO-2007106186-A2 | RESORCINOL RESIN-BLOCKED ISOCYANATES AND THEIR APPLICATIONS | INDSPEC CHEMICAL CORPORATION (US) | 2007-09-20 | — | — | WO | disclosed |
| US-20070219306-A1 | Resorcinol Resin-Blocked Isocyanates and Their Applications | INDSPEC CHEMICAL CORPORATION (US) | 2007-09-20 | — | — | US | disclosed |
| WO-2007100399-A1 | RESORCINOL-BLOCKED ISOCYANATE COMPOSITIONS AND THEIR APPLICATIONS | INDSPEC CHEMICAL CORPORATION (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20070205393-A1 | Resorcinol-Blocked Isocyanate Compositions and Their Applications | INDSPEC CHEMICAL CORPORATION (US) | 2007-09-06 | — | — | US | disclosed |
| US-20060093932-A1 | Bisazo-based charge transport materials having 4-oxo-2,5-cyclohexadiene-1-ylidinyl groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-05-04 | — | — | US | disclosed |
| US-4187247-A | ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1980-02-05 | — | — | US | disclosed |
| US-4163103-A | ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1979-07-31 | — | — | US | disclosed |
| US-4107190-A | ANTITUMOR | HOFFMANN-LA ROCHE INC. (US) | 1978-08-15 | — | — | US | disclosed |
| US-4054589-A | ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1977-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12303970-B2 | Foundry mix including resorcinol | PRRC2C, ASH2L, RCOR1 | CYP3A4 1131/4885MEN1 2256/4885KMT2A 3177/4885 |
| US-11712735-B2 | Foundry mix including resorcinol | PRRC2C, RCOR1, ASH2L | CYP3A4 1141/4885MEN1 2476/4885KMT2A 3351/4885 |
| US-20060093932-A1 | Bisazo-based charge transport materials having 4-oxo-2,5-cyclohexadiene-1-ylidinyl groups | SLCO2A1, SLCO2B1, SLC25A21 | CYP3A4 1802/4885MEN1 2979/4885KMT2A 3132/4885 |
| US-20230321717-A1 | FOUNDRY MIX INCLUDING RESORCINOL | PRRC2C, ASH2L, RCOR1 | CYP3A4 1131/4885MEN1 2256/4885KMT2A 3177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.